SEARCH THE AGT WEBSITE
WEBSITE CONTENT OVERVIEW
Subscribe to Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about American Gene Technologies!
Follow AGT on Social Media
AGT on Facebook
Jeff Galvin, CEO of American Gene Technologies, shares his journey from Silicon Valley to biotech and the future of gene therapy. Watch the interview on Bio Blast!![]()
www.addimmune.com/jeff-galvin-explains-agts-innovative-approach-to-hiv-on-bio-blast/![]()
#genetherapy #biotech #Innovation
Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. ![]()
loom.ly/96TZ0jU![]()
#HIV #celltherapy #biotech
M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest.
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! ![]()
loom.ly/jAThqIU![]()
#HIV #hivcure #HIVresearch #clinicaltrials
